Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2021 Results Earnings Conference Call November 3, 2021 4:15 PM ET Company Participants David Szekeres - Executive Vice President, Chief Operating Officer Barry Quart - Chief Executive Officer and Chairman of the Board John Poyhonen - President and Chief Commercial Officer; Kimberly Manhard - Executive Vice President, Drug Development and Director Conference Call Participants Joshua Schimmer - Evercore ISI Brandon Folkes - Cantor Fitzgerald Boris Peaker - Cowen Serge ...